Grown Rogue International (GRIN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Achieved positive cash flow from operations and net income of $2.5M for the six months ended June 30, 2025, reversing a net loss of $11.7M year-over-year.
Maintained profitability and operational resilience through cost controls, yield improvements, and lower expenses.
Expansion efforts continue in New Jersey, Illinois, and Minnesota, with new licenses and facility construction underway.
Focused on long-term growth, not dependent on federal reform, leveraging low-cost production as a competitive advantage.
Major restructuring of convertible debentures and share capital completed.
Financial highlights
Six-month revenue declined 22% year-over-year to $11.1M, with gross profit at $4.6M and gross margin at 41%.
Operating cash flow for the six months was $3.3M, up from $425K in the prior year.
Cash and cash equivalents increased to $9.3M from $4.7M at year-end.
Production costs in Michigan dropped below $400/lbs, Oregon in the mid $400s, with indoor costs estimated sub-$200/lbs.
Adjusted EBITDA remained strong despite a significant pricing decline in core markets.
Outlook and guidance
Expecting continued recovery in Oregon and Michigan pricing after recent troughs.
New Jersey phase II construction to complete by early Q2 2026, targeting 1,200 lbs/month capacity.
Anticipate capital-efficient growth from distressed industry opportunities over the next 12-18 months.
Management expects ABCO to resume payments on defaulted notes within twelve months.
No major customer concentration risk anticipated for the remainder of the year.
Latest events from Grown Rogue International
- Pro Forma Revenue up 26% year-over-year, driven by yield gains and new market expansion.GRIN
Q3 202517 Nov 2025 - Record revenue and aEBITDA growth, with expansion into New Jersey and Illinois underway.GRIN
Q2 202420 Aug 2025 - Q3 2024 revenue up 7% to $7.0M; New Jersey operations launched; Michigan margins improved.GRIN
Q3 202420 Aug 2025 - 2024 revenue rose 16% to $27.0M, with adjusted EBITDA up 27% and rapid New Jersey expansion.GRIN
Q4 202420 Aug 2025 - Expanding multi-state cannabis producer delivers strong growth, efficiency, and brand loyalty.GRIN
Investor Presentation20 Aug 2025 - Revenue up 7% year-over-year, but Adjusted EBITDA down 31% due to pricing pressure.GRIN
Q1 202520 Aug 2025